相关实验视频
Updated: Jan 16, 2026

07:50
Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer
Published on: September 18, 2020
6.1K
早期和晚期胃癌的分子特征:系统性审查和元分析
Xinmei Lin1,2,3, Wenhan Shi1,3, Zitong Zhou4
1Digestive Diseases Center, The Seventh Affiliated Hospital, Sun Yat-Sen University, Shenzhen, Guangdong, China.
BMC cancer
|January 15, 2026
概括
早期出现的胃癌 (EOGC) 具有独特的分子特征,与晚发胃癌 (LOGC) 有显著差异. 了解这些差异是制定EOGC有针对性的诊断和治疗策略的关键.
科学领域:
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
- 分子生物学分子生物学
背景情况:
- 在50岁之前诊断的早期胃癌 (EOGC) 具有独特的临床病理学特征.
- 与晚发性胃癌 (LOGC) 相比,EOGC的分子格局仍然不完全理解.
研究的目的:
- 系统地比较EOGC和LOGC的分子特性.
- 识别与EOGC相关的不同的基因组,生物标志物和血清标志物配置文件.
主要方法:
- 在PubMed,Embase和Web of Science进行了全面的文献搜索.
- 进行了元分析,以评估EOGC和LOGC之间的癌症基因组图谱 (TCGA) 分子类型,基因突变,治疗生物标志物和血清瘤标志物的差异.
主要成果:
- EOGC显示基因组稳定 (GS) 亚型的患病率较高,染色体不稳定 (CIN) 亚型的患病率较低.
- 在EOGC中,CDH1突变更频繁,而HER2表达,dMMR/MSI-H状态和p53表达明显较低.
- 血清瘤标志物如CEA和CA19-9在EOGC患者中较少升高.
结论:
- EOGC是胃癌中的一个生物学上独特的实体,具有独特的基因组和免疫特征.
- 这些发现提倡针对胃癌的特定年龄的诊断策略.
- 多原子方法对于阐明EOGC的潜在机制至关重要.
更多相关视频
相关概念视频
Barrett Esophagus-II: Clinical Manifestations and Management
790
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
790
Cancer Survival Analysis
645
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
645
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Gastroesophageal Reflux Disease II: Clinical Features and Management
689
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
689
Barrett Esophagus-I: Introduction
630
Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
630
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K

